490 069 emdogain 20y flyer en low

Share a clinical case treated with Emdogain速 with your fellow dental professionals.

490.069_Emdogain 20Y_Flyer.indd 2

10.07.15 09:17

More than 20 years of periodontal regeneration – Straumann® Emdogain®

YES, IT HAS BEEN 20 YEARS SINCE EMDOGAIN® WAS FIRST LAUNCHED IN EUROPE! Over the past 20 years, Straumann® Emdogain® has proven to be an effective solution to treat patients with periodontitis by inducing the regeneration of lost periodontal tissues, and to provide improved patient satisfaction (compared to other methods) thanks to better healing, less surgical complications, and long-term clinical benefits.

Emdogain® in numbers: ѹѹ Over 2 million patients treated1 ѹѹ Stable results documented for over 10 years in 2 indications2 ѹѹ Over 800 scientific publications ѹѹ Over 400 clinical publications ѹѹ Almost no side effects3

Post op Courtesy of Prof. Carlos Nemcovsky, Israel

20 years follow up

1 Based on the number of syringes sold 2 McGuire MK, Scheyer ET, Nunn M. Evaluation of human recession defects treated with coronally advanced flaps and either enamel matrix derivative or connective tissue: comparison of clinical parameters at 10 years. J Periodontol. 2012 Nov;83(11):1353-62/2. Sculean A, et al. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol. 2008 Sep;35(9): 817-24 3 Post surgery complication rate < 0.002 %

490.069_Emdogain 20Y_Flyer.indd 3

10.07.15 09:17

CELEBRATE WITH US THE 20TH ANNIVERSARY OF EMDOGAIN®, SHARE A CLINICAL CASE TREATED WITH EMDOGAIN® WITH YOUR FELLOW DENTAL PROFESSIONALS.

Where will the cases be shown? ѹѹ All cases will be displayed on a digital platform of cases accessible worldwide. ѹѹ Selected cases will be included in the new Emdogain® casebook which will be published by the end of 2015.

What is the process? ѹѹ Fill out the online case collection form online at straumann.com/EmdogainCases OR ѹѹ Fill out the case collection form document available at straumann.com/ EmdogainCases and submit it along with all the requested documentation to regen@straumann.com. ѹѹ Deadlines for submission: ѹѹ General deadline: 31 December 2015 ѹѹ To be considered for the printed casebook: 19 June 2015 Prize: ѹѹ Everyone who submits a fully documented clinical case will receive a “20 years of Emdogain®” surgical suit! ѹѹ Three out of all cases with at least 12 years of follow-up that are being submitted before 19 June 2015 will be drawn and receive an iPad Air 2! iPad® is a trademark of Apple Inc., registered in the U.S. and other countries.

490.069_Emdogain 20Y_Flyer.indd 4

10.07.15 09:17

SIGN UP TODAY TO BE AMONG THE FIRST CLINICIANS TO TRY STRAUMANN® OSTEOGAIN™!

Straumann® Osteogain™ is a new biologic solution that has been developed and optimized for mixing with bone graft materials and collagen substrates to stimulate bone formation as part of regenerative bone augmentation procedures.

Register today on straumann.com/osteogain and get your 3 free samples for clinical use!*

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01 www.straumann.com

© Institut Straumann AG, 2015. All rights reserved.

Straumann® and/or other trademarks and logos from Straumann® mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates.

490.069_Emdogain 20Y_Flyer.indd 1

490.069/en/A/00 04/15

* as soon as Straumann® Osteogain™ is available in your market

10.07.15 09:17